Physicians' Academy for Cardiovascular Education

Biology and validation of PCSK9 as a novel target to lower LDL-C

Prof. John JP Kastelein

10' education - Aug. 30, 2014 - Barcelona, ESC - Prof. John JP Kastelein

Educational information

The programme was CME accredited by EBAC

Lecture by Prof. John Kastelein, Amsterdam, The Netherlands, held during EBAC accredited symposium 'Managing Innovations in lipid management: Evolving insights and implications from PCSK9 research' held during ESC2014 in Barcelona

Start video

Share this page with your colleagues and friends: